On Sun, 2009-02-22 at 20:54 +0000, Simon Ward wrote: > The Biotech model is experiencing severe problems at present given that it's > built on credit secured on the promise of future earnings. With drugs being > pressured both by genetrics and by a seeming inability to turn gene mapping > into successful products, the credit, be it debt or shares, appears to be > drying up.
Yes but the intellectual property landmines will stay there for twenty years (at least, incremental patenting keep extending). You don't need product or sales to sue for intellectual property violation see the well-known patent trolls currently in activity. Laurent _______________________________________________ pen-l mailing list [email protected] https://lists.csuchico.edu/mailman/listinfo/pen-l
